Efficacy of Amniotic Membrane wrapped Anterior Cruciate Ligament reconstruction

Efficacy of Amniotic Membrane wrapped Anterior Cruciate Ligament reconstruction An Prospective Comparative Study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099990

Enrollment

Registered

2025-12-31

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M242- Disorder of ligament

Interventions

Intervention1: Efficacy of Amniotic Membrane Wrapped Anterior Cruciate Ligament Reconstruction: Amniotic Membrane Wrapped Anterior Cruciate Ligament Reconstruction with DTI MRI at 6 months follow up C

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age : 18-45 years 2. Patients who have consented for using amnion augmented grafts. 3. Patients who have undergone arthroscopic ACL reconstruction using peroneus longus autograft in department of Orthopaedics, AIIMS, Rishikesh 4. Patients/parents willing to give written and informed consent

Exclusion criteria

Exclusion criteria: 1. Multiligamentous injury(Grade II or higher PCL, LCL and MCL) 2. Associated meniscal injuries requiring menisectomy 3. Associated femoral or tibial condylar fracture 4. Associated fracture involving the same limb(femur, tibia, ankle)

Design outcomes

Primary

Measure	Time frame
To assess graft maturation on Diffuse Tensor Imaging -MRI following Amniotic membrane wrapped ACL with Arthroscopic ACL reconstruction (FA & ADC) v/s Routine Arthroscopic ACL reconstruction ATTimepoint: 6 months	—

Secondary

Measure	Time frame
Lysholm Knee Score & IKDCTimepoint: 6 MONTHS	—

Countries

India

Contacts

Public ContactDr Siddhartha Singh

AIIMS Rishikesh

dr.pradsms@gmail.com08318006778

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026